[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:metastatic-malignant-neoplasm-in-the-liver":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":97,"states":98},"Metastatic Malignant Neoplasm in the Liver",14,13,[8,16,22,28,34,40,47,53,59,66,72,78,83,89],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05062317","ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases",[12],"Phase 2","RECRUITING","2026-08-26T02:17:15.156099Z","2026-05-05T02:43:29.727219Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05588388","Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases",[12],"2026-08-26T02:18:41.390601Z","2026-05-05T02:43:29.356266Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06130280","A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer",[12],"2026-08-26T02:15:31.806698Z","2026-05-05T02:43:28.557756Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT01697371","Proton Therapy in the Treatment of Liver Metastases",[],"2026-08-26T02:15:10.362237Z","2026-05-05T02:43:28.216014Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":38,"content_modified":39},"NCT04020276","OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases",[],"2026-08-26T02:16:41.943926Z","2026-05-05T02:43:27.574867Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":45,"content_modified":46},"NCT07277322","Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases",[44],"Phase 1\u002FPhase 2","2026-08-26T02:19:15.498463Z","2026-05-05T02:43:26.932462Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT07225036","Promoting Immunotherapy Efficacy With Low-Dose Liver RT",[],"2026-08-26T02:16:36.513735Z","2026-05-05T02:43:28.706891Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT07223307","REGULUS: MRI-guided Adaptive SABR for Liver Cancers",[12],"2026-08-26T02:18:22.309547Z","2026-05-05T02:43:27.107508Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":64,"content_modified":65},"NCT04143516","Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment",[63],"Phase 2\u002FPhase 3","2026-08-26T02:18:31.944757Z","2026-05-05T02:43:27.174103Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT06899152","HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer",[],"2026-08-26T02:19:14.560989Z","2026-05-05T02:43:29.192698Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT06486454","Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)",[],"2026-08-26T02:18:34.622081Z","2026-05-13T02:55:06.494980Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":45,"content_modified":82},"NCT07717437","DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE\u002FHVE) to Increase Future Liver Remnant Before Resection.",[],"2026-07-24T01:27:14.913539Z",{"nct_id":84,"title":85,"phases":86,"status":13,"updated_at":87,"content_modified":88},"NCT07044362","Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis",[],"2026-08-26T02:15:02.712396Z","2026-05-05T02:43:26.740284Z",{"nct_id":90,"title":91,"phases":92,"status":94,"updated_at":95,"content_modified":96},"NCT05430009","Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer",[93],"Phase 1","UNKNOWN","2026-08-03T03:05:09.265674Z","2026-05-05T02:43:28.211344Z",[],[99,103,107,110],{"state":100,"count":101,"slug":102},"New York",5,"new-york",{"state":104,"count":105,"slug":106},"California",4,"california",{"state":108,"count":105,"slug":109},"Ohio","ohio",{"state":111,"count":112,"slug":113},"Michigan",3,"michigan"]